SEARCH

SEARCH BY CITATION

References

  • Abdelkarim G. E., Gertz K., Harms C., Katchanov J., Dirnagl U., Szabo C. and Endres M. (2001) Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke. Int. J. Mol. Med. 7, 255260.
  • Agnello D., Wang H., Yang H., Tracey K. J. and Ghezzi P. (2002) HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 18, 231236.
  • Allain F. H., Yen Y. M., Masse J. E., Schultze P., Dieckmann T., Johnson R. C. and Feigon J. (1999) Solution structure of the HMG protein NHP6A and its interaction with DNA reveals the structural determinants for non-sequence-specific binding. EMBO J. 18, 25632579.
  • Barone F. C. and Feuerstain G. Z. (1999) Inflammatory mediators and stroke: novel opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819834.
  • Bianchi M. E. (2004) Significant (re)location: how to use chromatin and/or abundant proteins as messages of life and death. Trends Cell Biol. 14, 287293.
  • Bianchi M. E. (2007) DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81(1), 15.
  • Bonaldi T., Talamo F., Scaffidi P., Ferrera D., Porto A., Bachi A., Rubartelli A., Agresti A. and Bianchi M. E. (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J. 22, 55515560.
  • Chiarugi A. (2002) Characterization of the molecular events following impairment of NF-kappaB-driven transcription in neurons. Brain Res. Mol. Brain Res. 109, 179188.
  • Chiarugi A. and Moskowitz M. A. (2003) Poly(ADP-ribose) polymerase-1 activity promotes NF-kappaB-driven transcription and microglial activation: implication for neurodegenerative disorders. J. Neurochem. 85, 306317.
  • Chou D. K., Zhang J., Smith F. I., McCaffery P. and Jungalwala F. B. (2004) Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration. J. Neurochem. 90, 13891401.
  • Cipriani G., Rapizzi E., Vannacci A., Rizzuto R., Moroni F. and Chiarugi A. (2005) Nuclear poly(ADP-ribose) polymerase-1 rapidly triggers mitochondrial dysfunction. J. Biol. Chem. 280, 1722717234.
  • Clark A. (2000) Post-transcriptional regulation of pro-inflammatory gene expression. Arthritis Res. 2, 172174.
  • Ding Q. and Keller J. N. (2005) Evaluation of rage isoforms, ligands, and signaling in the brain. Biochim. Biophys. Acta 1746, 1827.
  • Dirnagl U., Iadecola C. and Moskowitz M. A. (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci. 22, 391397.
  • Dumitriu I. E., Baruah P., Manfredi A. A., Bianchi M. E. and Rovere-Querini P. (2005) HMGB1: guiding immunity from within. Trends Immunol. 26, 381387.
  • Ellwood K. B., Yen Y. M., Johnson R. C. and Carey M. (2000) Mechanism for specificity by HMG-1 in enhanceosome assembly. Mol. Cell. Biol. 20, 43594370.
  • Faraco G., Pancani T., Formentini L., Mascagni P., Fossati G., Leoni F., Moroni F. and Chiarugi A. (2006) Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain. Mol. Pharmacol. 70, 18761884.
  • Gardella S., Andrei C., Ferrera D., Lotti L. V., Torrisi M. R., Bianchi M. E. and Rubartelli A. (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 3, 9951001.
  • Giancotti V., Bandiera A., Sindici C., Perissin L. and Crane-Robinson C. (1996) Calcium-dependent ADP-ribosylation of high mobility-group I (HMGI) proteins. Biochem. J. 317, 865870.
  • Goldstein R. S., Gallowitsch-Puerta M., Yang L. et al. (2006) Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 25, 571574.
  • Guazzi S., Strangio A., Franzi A. T. and Bianchi M. E. (2003) HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain. Gene Expr. Patterns. 3, 2933.
  • Ha H. C. and Snyder S. H. (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc. Natl Acad. Sci. 69, 1397813982.
  • Iadecola C. and Alexander M. (2001) Cerebral ischemia and inflammation. Curr. Opin. Neurol. 14, 8994.
  • Killeen M. E., Englert J. A., Stolz D. B., Song M., Han Y., Delude R. L., Kellum J. A. and Fink M. P. (2006) The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells. J. Pharmacol. Exp. Ther. 316, 10701079.
  • Kim J. B., Sig C. J., Yu Y. M., Nam K., Piao C. S., Kim S. W., Lee M. H., Han P. L., Park J. S. and Lee J. K. (2006) HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain. J. Neurosci. 26, 64136421.
  • Koh J. Y. and Choi D. W. (1987) Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20, 8390.
  • Konat G. W., Kielian T. and Marriott I. (2006) The role of toll-like receptors in CNS response to microbial challenge. J. Neurochem. 99, 112.
  • Landsman D. and Bustin M. (1993) A signature for the HMG-1 box DNA-binding proteins. Bioessays 15, 539546.
  • Limana F., Germani A., Zacheo A. et al. (2005) Exogenous high-mobility group box 1 protein induces myocardial regeneration after infarction via enhanced cardiac C-kit+ cell proliferation and differentiation. Circ. Res. 97, e73e83.
  • Lo E. H., Dalkara T. and Moskowitz M. A. (2003) Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399415.
  • Lotze M. T. and Tracey K. J. (2005) High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5, 331342.
  • Moroni F., Meli E., Peruginelli F, Chiarugi A., Cozzi A., Picca R., Romagnoli P., Pellicciari R. and Pellegrini-Giampietro D. E. (2001) Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Diff. 8, 921932.
  • O’Connor K. A., Hansen M. K., Rachal P. C. et al. (2003) Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine 24, 254265.
  • Oppenheim J. J. and Yang D. (2005) Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359365.
  • Pallier C., Scaffidi P., Chopineau-Proust S., Agresti A., Nordmann P., Bianchi M. E. and Marechal V. (2003) Association of chromatin proteins high mobility group box (HMGB) 1 and HMGB2 with mitotic chromosomes. Mol. Biol. Cell 14, 34143426.
  • Passalacqua M., Patrone M., Picotti G. B., Del Rio M., Sparatore B., Melloni E. and Pontremoli S. (1998) Stimulated astrocytes release high-mobility group 1 protein, an inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience 82, 10211028.
  • Pedrazzi M., Raiteri L., Bonanno G. et al. (2006) Stimulation of excitatory amino acid release from adult mouse brain glia subcellular particles by high mobility group box 1 protein. J. Neurochem. 99, 827838.
  • Rauvala H. and Pihlaskari R. (1987) Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J. Biol. Chem. 262, 1662516635.
  • Rioja I., Bush K. A., Buckton J. B., Dickson M. C. and Life P. F. (2004) Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. Clin. Exp. Immunol. 137, 6573.
  • Sakamoto R., Okano M., Takena H. and Ohtsuki K. (2001) Inhibitory effect of glycyrrhizin on the phosphorylation and DNA-binding abilities of high mobility group proteins 1 and 2 in vitro. Biol. Pharm. Bull. 24, 906911.
  • Scaffidi P., Misteli T. and Bianchi M. E. (2002a) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191195.
  • Seko Y., Cole S., Kasprzak W., Shapiro B. A. and Ragheb J. A. (2006) The role of cytokine mRNA stability in the pathogenesis of autoimmune disease. Autoimmun. Rev. 5, 299305.
  • Sparatore B., Passalacqua M., Patrone M., Melloni E. and Pontremoli S. (1996) Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell differentiation. Biochem. J. 320 (part 1), 253256.
  • Swanson R. A. and Sharp F. R. (1994) Infarct measurement methodology. J. Cereb. Blood Flow Metab. 14, 697698.
  • Takata K., Kitamura Y., Kakimura J., Shibagaki K., Tsuchiya D., Taniguchi T., Smith M. A., Perry G. and Shimohama S. (2003) Role of high mobility group protein-1 (HMG1) in amyloid-beta homeostasis. Biochem. Biophys. Res. Commun. 301, 699703.
  • Takata K., Kitamura Y., Tsuchiya D., Kawasaki T., Taniguchi T. and Shimohama S. (2004) High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity. J. Neurosci. Res. 78, 880891.
  • Ulloa L. and Messmer D. (2006) High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev. 17, 189201.
  • Ulloa L., Ochani M., Yang H., Tanovic M., Halperin D., Yang R., Czura C. J., Fink M. P. and Tracey K. J. (2002) Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl Acad. Sci. USA 99, 1235112356.
  • Verrijdt G., Haelens A., Schoenmakers E., Rombauts W. and Claessens F. (2002) Comparative analysis of the influence of the high-mobility group box 1 protein on DNA binding and transcriptional activation by the androgen, glucocorticoid, progesterone and mineralocorticoid receptors. Biochem. J. 361, 97103.
  • Volterra A. and Meldolesi J. (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 6, 626640.
  • Wang H., Vishnubhakat J. M., Bloom O., Zhang M., Ombrellino M., Sama A. and Tracey K. J. (1999) Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126, 389392.
  • Yu S. S., Li H. J., Goodwin G. H. and Johns E. W. (1977) Interaction of non-histone chromosomal proteins HMG1 and HMG2 with DNA. Eur. J. Biochem. 78, 497502.
  • Yu S. W., Poitras M. F., Coombs C., Bowers W. J., Federoff H. J., Poirier G. G., Dawson T. M. and Dawson V. L. (2002) Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science 297, 259263.